15/12/2025 14:35
Morgan Stanley raised the target price for Ali Health (00241) to HKD4.6 from HKD4.2 and maintained the "underweight" rating.
The research house said it raises FY26-28e revenue by 5.5%/6.7%/7.1%, respectively, reflecting the strong sales momentum in the online drug segment and the updated company guidance.
【樂本健11月限時優惠！】 憑獨家優惠碼【ETN2511】，購物滿$500即送免費禮品► 了解詳情
上一篇新聞︰15/12/2025 16:00 {I-bank focus}Citi raises Li Ning (02331) to HKD20.6
下一篇新聞︰12/12/2025 16:08 {I-bank focus}Citi lowers China Res Power (00836) to HKD19
12/12/2025 14:40 {I-bank focus}Morgan raises COSCO Ship Hold to HKD10.3
11/12/2025 16:05 {I-bank focus}UBS lowers Giant Biogene (02367) to HKD39.5
11/12/2025 14:32 {I-bank focus}J.P. Morgan lowers Brilliance Chi to HKD4.1
09/12/2025 16:02 {I-bank focus}Citi lowers HKEX (00388) to HKD505
09/12/2025 15:10 {I-bank focus}Citi raises Brilliance Chi (01114) to HKD4.8
